A US private equity firm has acquired Optum UK in a deal worth about $400m (£300m), transferring control of the healthcare technology business behind the electronic patient record system used by most GP practices in England, according to reports. According to experts and campaign groups, the transaction involving the primary care software provider EMIS should ring alarm bells over the handling of sensitive health data by private companies with little public oversight.
Private Equity Takeover of NHS Primary Care Technology
The acquisition places the electronic health records of millions of patients under the control of New York-headquartered investment firm TPG, which bought Optum UK from the New York-listed healthcare corporation UnitedHealth Group. Through its subsidiary EMIS, the company provides software utilized by more than half of GP practices across England. According to a spokesperson for the campaign group Doctors’ Association UK (DAUK), private equity now owns the plumbing of English general practice.
“The GP records of more than half the country sit on a system controlled by a firm whose business model is returns for investors, not care for patients, and the public found out after the fact,” said a DAUK spokesperson. The group added that while previous concerns focused on tech firm Palantir, this new acquisition involves a private equity giant whose overseas healthcare investments have faced sharp criticism.
Did you know?
EMIS software is currently utilized by more than 50% of all general practice surgeries in England, making it one of the most critical foundational pillars of NHS primary care data infrastructure.
Scrutiny Over Overseas Healthcare Track Record
Critics have pointed to TPG’s international healthcare investments as a core reason for concern regarding the security and ethical management of patient data. An investigation published earlier in the year by the International Consortium of Investigative Journalists (ICIJ) examined hospitals in Kenya owned by Evercare, a healthcare group backed by TPG’s Rise Fund. The ICIJ investigation reported allegations that some patients faced crippling medical debts and, in certain instances, were required to provide land deeds as collateral for unpaid bills.
Anna Marriott, the former Oxfam health policy lead, stated that the transaction should trigger major regulatory warnings. “It is deeply concerning that a private equity firm with a highly controversial track record in healthcare internationally can take control of sensitive NHS patient data with so little public scrutiny,” Marriott said, noting that NHS patients have no say over who holds their medical records.
In response to the ICIJ findings, a spokesperson for TPG stated that the firm strongly disagreed with the facts and characterization of the allegations. “We’ve made more than $100m of investments across Evercare over six years, which have led to substantial gains in quality, accessibility, and accreditations, as well as patient rights and protections,” the TPG spokesperson said. “Any suggestion that TPG or Evercare prioritises profits over patients is incorrect and ignores the extensive clinical governance and patient’s rights policies we’ve instituted.”
Political Response and Regulatory Safeguards
Helen Morgan, the Liberal Democrats’ health spokesperson, argued that such arrangements are being rubber-stamped without adequate protections for patients. “Time and time again, patients are seeing the government hand over sensitive NHS data to US tech firms, leaving our public services dangerously exposed,” Morgan said, urging the government to support domestic technology providers instead.
A spokesperson for EMIS emphasized that data security remains central to operations. “We have a longstanding commitment to the NHS and the wider UK healthcare system,” the EMIS spokesperson said, adding that the acquisition was reviewed and approved by the UK government via channels compliant with the National Security and Investment Act 2021.
Echoing these assurances, a spokesperson for TPG stated: “Assertions that TPG could in any way access, control, maintain, or utilise NHS patient records are entirely false. A change in ownership of the company has in no way changed how patient data is stored, protected, or governed, nor has it altered the legal, regulatory, contractual, and operational safeguards that apply.” The Department of Health and Social Care did not provide a comment on the transaction.
Frequently Asked Questions
Who bought Optum UK and EMIS?
US private equity firm TPG acquired Optum UK from UnitedHealth Group in a deal valued at approximately $400m (£300m). Optum UK includes EMIS, a primary care software provider.
Does the change in ownership affect NHS patient data security?
According to representatives for both EMIS and TPG, the acquisition does not alter legal, regulatory, or contractual safeguards, and TPG cannot directly access or control patient records.
Was the deal reviewed by the UK government?
Yes, representatives for EMIS confirmed that the acquisition underwent review and approval through official channels in accordance with the National Security and Investment Act 2021.
Want to stay informed on NHS policy developments and healthcare technology? Subscribe to our newsletter for daily updates.